Submitted:
14 October 2026
Posted:
15 October 2026
You are already at the latest version
Abstract
The scientific work of Professor William W. Muir addresses a fundamental problem in oxygen therapeutics: increasing oxygen transport capacity does not necessarily mean that oxygen reaches the tissues where it is needed. Over several decades, Muir investigated cardiovascular physiology, respiratory gas exchange, hemorrhagic shock, microvascular perfusion, hemoglobin-based oxygen carriers (HBOCs), and tissue oxygenation. His scientific involvement with Biopure, collaboration with Carl W. Rausch, and subsequent reported advisory activities in veterinary product development form an important part of this history. This article traces the development of these ideas and their experimental evaluation, leading to a proposed next step: Precision Oxygen Therapeutics based on Biological Hemoglobin Oxygen Carrier (BHOC), with oxygen delivery treated as a distinct therapeutic function rather than an attempt to replace blood.
Keywords:
William W. Muir
; oxygen delivery
; tissue oxygenation
; veterinary medicine
; hemoglobin-based oxygen carriers
; oxyglobin
; microcirculation
; precision oxygen therapeutics
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.